IBB ETF holdings (NASDAQ) - Page 11 | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

PRME Prime Medicine, Inc. 2.45 M 704.09 K 0.03%

KROS Keros Therapeutics, Inc. 2.37 M 214.79 K 0.03%

FLGT Fulgent Genetics, Inc. 2.37 M 148.75 K 0.03%

TECX Tectonic Therapeutic, Inc. 2.35 M 75.89 K 0.03%

AURA Aura Biosciences, Inc. 2.26 M 338.13 K 0.03%

KYTX Kyverna Therapeutics, Inc. 2.17 M 251.26 K 0.03%

MRVI Maravai LifeSciences Holdings, Inc. 2.15 M 759.05 K 0.03%

IMRX Immuneering Corp. 2.06 M 390.01 K 0.03%

AVXL Anavex Life Sciences Corp. 2.05 M 668.45 K 0.03%

TRDA Entrada Therapeutics, Inc. 2.00 M 158.27 K 0.02%

DNA Ginkgo Bioworks Holdings, Inc. 1.95 M 317.32 K 0.02%

UPB Upstream Bio, Inc. 1.92 M 213.03 K 0.02%

NGNE Neurogene, Inc. 1.91 M 94.69 K 0.02%

LENZ LENZ Therapeutics, Inc. 1.89 M 206.97 K 0.02%

AUTL Autolus Therapeutics plc 1.82 M 1.32 M 0.02%

EDIT Editas Medicine, Inc. 1.81 M 731.16 K 0.02%

CABA Cabaletta Bio, Inc. 1.70 M 633.35 K 0.02%

CCCC C4 Therapeutics, Inc. 1.60 M 608.84 K 0.02%

LRMR Larimar Therapeutics, Inc. 1.58 M 350.41 K 0.02%

CADL Candel Therapeutics, Inc. 1.45 M 295.00 K 0.02%

1
...
6
7
8
9
10
11
12
13

Notizie

UBS elenca 5 motivi chiave per cui le azioni biotech a media capitalizzazione dovrebbero performare bene nel 2026